T-cell Receptor α/β Depleted Donor Lymphocyte Infusion

Clinical trial NCT05350163 · TERMINATED

Trial details

NCT number: NCT05350163
Sponsor: Guenther Koehne
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoid Leukemia, Acute Myeloid Malignancy Plasma Cell Tumor

Start date: 2022-04-05
Primary completion: 2023-09-18
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.